Skip to main content
. 2022 May 17;10:839986. doi: 10.3389/fcell.2022.839986

FIGURE 5.

FIGURE 5

Construction of a KCNK-based prognostic signature for breast cancer. (A) Selection of the seven model KCNK genes in lasso regression model. (B) Cross-validation of the constructed signature. (C,D) Distribution of adjusted risk score in the training and validation cohorts. (E) Overall survival (OS) in the low- and high-risk group patients in the training and validation cohorts. The specific prognostic signature with seven KCNK genes was established, which manifested accuracy in predicting the prognosis of breast cancer in both training and validation cohorts.